Gsk crisis ppt


Published on

Published in: Technology, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • {}
  • Gsk crisis ppt

    1. 1. GlaxoSmithKline Scandal Shiqiao Peng
    2. 2. History and Background • The GlaxoSmithKline (GSK) is “a science-led healthcare company that researches and develops a broad range of innovative medicines and brands”. • LOCATION With the headquarters in the UK, GSK has offices in more than 115 countries, such as UK, USA, Spain, Belgium, and China. • GOAL “We are dedicated to improving the quality of human life by enabling people to do more, feel better, and live longer.” • GSK China GSK is one of the largest transnational pharmacy organizations in China. GSK has invested over 500 million dollars and has created more than 7,000 jobs and running a number of factories in China.
    3. 3. The Scandal • In June 2013, news reports pointed out that GSK’s staff bribed doctors to prescribe drugs . Xinhua news agency reported that a Glaxo sales manager said that the company’s representatives “established good personal relations with doctors by catering to their pleasure or offering them money, in order to make them prescribe more drugs”. • GSK issued a statement telling that no evidence has found to support that report. • The Ministry of Public Security in China conducted investigation into the organization and found Glaxo used bribes and other benefits for doctors and other public officials to increase its sales. The payments for doctors and officials were “funneled through travel agencies, totaling approximately $450 million”. • 18 more Glaxo employees had been detained in the city of Zhengzhou, Henan Province on July 26.
    4. 4. Organizational Response • Verbal Response • July 11: We take all allegations of bribery and corruption seriously. We continuously monitor our businesses to ensure they meet our strict compliance procedures. We have done thins in China and found no evidence of bribery or corruption of doctors or government officials. However, if evidence of such activity is provided, we will act swiftly on it. • July 15: GSK “shares the desire of the Chinese authorities to root out corruption” and that GSK will “take all necessary action required by the outcome of this investigation” • July 22: Certain senior executives of GSK China who know our systems well, appear to have acted outside of our processes and controls which breaches Chinese law • Non-Verbal Response
    5. 5. Media Response • The Focus Report (CCTV) produced an episode telling the story of GSK crisis on July 16. The episode’s name is Reveal the untold story of GSK. The program explaines how GSK use travel agency to briber doctors and officials. Besides, it also blames GSK to spend the money on bribery and transfer the cost to customers. Another CCTV program News One Plus One also blamed GSK in a feature story, saying GSK’s advertisement of its fast growth in China is more like an irony today. • lists the timeline and news reports of GSK crisis on the right side of the website when you search “GSK” through East Moring News, Beijing Commercial Newspaper, China Daily, People Net, Southern Daily News, NTES Finance, Jinghua Times, Xinjin News, Beijing Youths Newspaper, and all major newspapers published news reports as the crisis progressed.
    6. 6. Stakeholders Response • Chinese Government • Medical Industry • Hospitals and Doctors • Other Foreign Firms in China • Ordinary Customers and Netizens
    7. 7. Recommendations • Environmental scanning • Internal Communication • Be careful with the statement
    8. 8. References AFP. (2013, July 25). Glaxo replaces chief of China unit at center of bribery inquiry. New York Times. Retrieved from: Barboza, D. (2013, July 11). GlaxoSmithKline accused of corruption by China. New York Times. Retrieved from: Barboza , D. (2013, July 17). China bars GlaxoSmithKline executive from leaving a bribery inquiry. New York Tim es. Retrieved from: Barboza, D. (2013, July 26). China details allegations against Glaxo. New York Times. Retrieved from: http:// GSK China. (2013). GSK in China. Retrieved from: GSK. (2013a). About us. Retrieved from: GSK. (2013b). China investigation. Retrieved from: GSK. (2013c). GSK statement regarding recent meeting with Chinese authorities. Retrieved from: cent-meeting-with-chinese-authorities.html Henning, P. (2013, July 29). Lessons from the Glaxo Case in China. New York Times. Retrieved from: Jack, A., Jenkins, P. & Oakley, D. (2013, Septem ber, 23). GlaxoSmithKline China sales face growing pressure. Retrieved from: Roland, D. (2013, July 24). Glaxo in China: History of a crisis. The Telegraph. Retrieved from:
    9. 9. Thank you!
    10. 10. Thank you!